Mathers Edward T
SEC insider (Form 3/4/5 filer). CIK 0001328625. Director at OnKure Therapeutics, Inc. (OKUR) and 7 other issuers. 45 reported Form 4/5 transactions since Sep 2024; latest on Aug 7, 2026. Located in NEW YORK, NY.
Companies Mathers Edward T has filed insider reports for
- OnKure Therapeutics, Inc. (OKUR): Director
- MBX Biosciences, Inc. (MBX): Director
- Trevi Therapeutics, Inc. (TRVI): Director
- RHYTHM PHARMACEUTICALS, INC. (RYTM): Director
- Korro Bio, Inc. (KRRO): 10% Owner
- SpyGlass Pharma, Inc. (SGP): 10% Owner
- NeueHealth, Inc. (NEUE): 10% Owner
- Senti Biosciences, Inc. (SNTI): Director
Mathers Edward T
CIK: 0001328625
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (45 total)
- Aug 7, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
22.4K shares- - Jun 4, 2026OKUR
OnKure Therapeutics, Inc.
AwardDirectStock Option (right to buy)
7.7K shares- - Jun 4, 2026MBX
MBX Biosciences, Inc.
AwardDirectStock option (right to buy)
12.5K shares- - Jun 3, 2026TRVI
Trevi Therapeutics, Inc.
AwardDirectNonstatutory Stock Option (right to buy)
35K shares- - Mar 12, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
OtherIndirect4.2K shares- - Mar 10, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect207.1K shares at avg. $11.11$2.3M - Mar 2, 2026RYTM
RHYTHM PHARMACEUTICALS, INC.
OtherIndirect4.2K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect738K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.4M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
PurchaseIndirect937.5K shares at avg. $16.00$15.0M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 7, 2026 |  OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 22,350 | - | - | Direct |
| Jun 4, 2026 | OKUR OnKure Therapeutics, Inc. | Award Stock Option (right to buy) | 7,650 | - | - | Direct |
| Jun 4, 2026 |  MBX MBX Biosciences, Inc. | Award Stock option (right to buy) | 12,500 | - | - | Direct |
| Jun 3, 2026 |  TRVI Trevi Therapeutics, Inc. | Award Nonstatutory Stock Option (right to buy) | 35,000 | - | - | Direct |
| Mar 12, 2026 |  RYTM RHYTHM PHARMACEUTICALS, INC. | Other | 4,199 | - | $0 | Indirect |
| Mar 10, 2026 |  KRRO Korro Bio, Inc. | Purchase | 207,100 | $11.11 | $2,300,881 | Indirect |
| Mar 2, 2026 | RYTM RHYTHM PHARMACEUTICALS, INC. | Other | 4,198 | - | $0 | Indirect |
| Feb 9, 2026 |  SGP SpyGlass Pharma, Inc. | Conversion | 737,962 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 1,370,168 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Purchase | 937,500 | $16.00 | $15,000,000 | Indirect |
1-10 of 45 transactions